joyjac
★    

Philippines,
2011-07-05 09:53
(5465 d 08:49 ago)

Posting: # 7207
Views: 6,260
 

 EMA: Two-Stage design [Two-Stage / GS Designs]

Hi colleagues,

The EMEA guideline states that it is acceptable to use a two-stage approach when attempting to demonstrate bioequivalence. Can anyone enlighten me on this kind of study design, steps to be taken, stopping criteria or can we automatically switch to stage 2 if the BE fails at stage 1? Thanks and regards.


Edit: Category changed. [Helmut]
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2011-07-05 21:38
(5464 d 21:04 ago)

@ joyjac
Posting: # 7211
Views: 5,152
 

 EMA: Two-Stage design

Dear Joy,

EMA does not specify a particular method. One of them (Potvin et al. 2008) we have discussed numerous times in the forum. See e.g. this post.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
147 visitors (0 registered, 147 guests [including 33 identified bots]).
Forum time: 18:43 CEST (Europe/Vienna)

Science is simply common sense at its best that is,
rigidly accurate in observation, and
merciless to fallacy in logic.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5